HUSCAP logo Hokkaido Univ. logo

Hokkaido University Collection of Scholarly and Academic Papers >

Sort by: In order: Results/Page Authors/Record:
Export metadata:
Showing results 1 to 20 of 32
 next >
TypeAuthor(s)TitleOther TitlesCitationCitation(alt)Issue Date
article (author version)Takahashi, Yuka; Kameda, Hiraku; Miya, Aika; Nomoto, Hiroshi; Cho, Kyu Yong; Nakamura, Akinobu; Nishimura, Hiroki; Kimura, Hirokazu; Suzuki, Masaru; Konno, Satoshi; Shimizu, Ai; Matsuno, Yoshihiro; Okamoto, Michinari; Motegi, Hiroaki; Iwata, Naoko; Fujisawa, Haruki; Suzuki, Atsushi; Sugimura, Yoshihisa; Miyoshi, Hideaki; Atsumi, TatsuyaLymphocytic panhypophysitis and anti-rabphilin-3A antibody with pulmonary sarcoidosis-Pituitary-6-Apr-2023
articleNomoto, Hiroshi; Takahashi, Akihiro; Nakamura, Akinobu; Kurihara, Hiroyoshi; Takeuchi, Jun; Nagai, So; Taneda, Shinji; Miya, Aika; Kameda, Hiraku; Cho, Kyu Yong; Miyoshi, Hideaki; Atsumi, TatsuyaAdd-on imeglimin versus metformin dose escalation regarding glycemic control in patients with type 2 diabetes treated with a dipeptidyl peptidase-4 inhibitor plus low-dose metformin : study protocol for a multicenter, prospective, randomized, open-label, parallel-group comparison study (MEGMI study)-Bmj open diabetes research and care-Nov-2022
articleNomoto, Hiroshi; Furusawa, Sho; Nakamura, Akinobu; Takeuchi, Jun; Nagai, So; Yokoyama, Hiroki; Sakuma, Ichiro; Taneda, Shinji; Kurihara, Yoshio; Aoki, Shin; Miya, Aika; Kameda, Hiraku; Cho, Kyu Yong; Atsumi, Tatsuya; Miyoshi, HideakiEffects of switching from a dipeptidyl peptidase-4 inhibitor to oral semaglutide on glucose metabolism in patients with type 2 diabetes : protocol for a multicentre, prospective, randomised, open-label, parallel-group comparison study (the SWITCH-SEMA 2 st-BMJ Open-May-2022
article (author version)Chiba, Koki; Kameda, Hiraku; Miya, Aika; Nomoto, Hiroshi; Cho, Kyu Yong; Nakamura, Akinobu; Jin, Shigeki; Matoba, Kotaro; Miyoshi, Hideaki; Atsumi, TatsuyaFalse Hypercortisolemia Due to Abnormal Albumin-Cortisol Binding in a Patient with Familial Dysalbuminemic Hyperthyroxinemia-Thyroid-10-Feb-2022
articleKamoshima, Hikaru; Nomoto, Hiroshi; Yamashita, Kumiko; Takahashi, Yuka; Tsuchida, Kazuhisa; Kuwabara, Saki; Miya, Aika; Cho, Kyu Yong; Kameda, Hiraku; Nakamura, Akinobu; Atsumi, Tatsuya; Taneda, Shinji; Kurihara, Yoshio; Aoki, Shin; Ono, Yuri; Miyoshi, HideakiDo the benefits of sodium-glucose cotransporter 2 inhibitors exceed the risks in patients with type 1 diabetes?-Endocrine journal-28-Jan-2022
articleCho, Kyu Yong; Nomoto, Hiroshi; Nakamura, Akinobu; Kawata, Shinichiro; Sugawara, Hajime; Takeuchi, Jun; Nagai, So; Omori, Kazuno; Tsuchida, Kazuhisa; Miya, Aika; Shigesawa, Ikumi; Tsuchida, Kenichi; Yanagiya, Shingo; Kameda, Hiraku; Yokoyama, Hiroki; Taneda, Shinji; Kurihara, Yoshio; Aoki, Shin; Nishimoto, Naoki; Atsumi, Tatsuya; Miyoshi, HideakiImproved Time in Range and Postprandial Hyperglycemia with Canagliflozin in Combination with Teneligliptin : Secondary Analyses of the CALMER study-Journal of Diabetes Investigation-10-Aug-2021
articleMiya, Aika; Nakamura, Akinobu; Cho, Kyu Yong; Kawata, Shinichiro; Nomoto, Hiroshi; Nagai, So; Sugawara, Hajime; Taneda, Shinji; Tsuchida, Kazuhisa; Omori, Kazuno; Yokoyama, Hiroki; Takeuchi, Jun; Aoki, Shin; Kurihara, Yoshio; Atsumi, Tatsuya; Miyoshi, HideakiImpact of endogenous insulin secretion on the improvement of glucose variability in Japanese patients type 2 diabetes treated with canagliflozin plus teneligliptin-Journal of Diabetes Investigation-10-Aug-2021
articleMiyoshi, Arina; Kameda, Hiraku; Nagai, So; Nakamura, Akinobu; Miya, Aika; Takase, Takahiro; Atsumi, Tatsuya; Miyoshi, HideakiBeneficial effects of switching to denosumab from bisphosphonates or selective estrogen receptor modulators in postmenopausal women with type 2 diabetes and osteopenia/osteoporosis-Journal of Diabetes Investigation-8-Jul-2021
articleCho, Kyu Yong; Nakamura, Akinobu; Omori, Kazuno; Takase, Takahiro; Miya, Aika; Yamamoto, Kohei; Nomoto, Hiroshi; Kameda, Hiraku; Taneda, Shinji; Kurihara, Yoshio; Aoki, Shin; Atsumi, Tatsuya; Miyoshi, HideakiFavorable effect of sodium–glucose cotransporter 2 inhibitor, dapagliflozin, on non‐alcoholic fatty liver disease compared with pioglitazone-Journal of Diabetes Investigation-8-Jul-2021
articleMiya, Aika; Nakamura, Akinobu; Handa, Takahisa; Nomoto, Hiroshi; Kameda, Hiraku; Cho, Kyu Yong; Nagai, So; Miyoshi, Hideaki; Atsumi, TatsuyaImpaired insulin secretion predicting unstable glycemic variability and time below range in type 2 diabetes patients regardless of glycated hemoglobin or diabetes treatment-Journal of diabetes investigation-May-2021
articleMiya, Aika; Nakamura, Akinobu; Handa, Takahisa; Nomoto, Hiroshi; Kameda, Hiraku; Cho, Kyu Yong; Nagai, So; Ito, Yoichi M.; Miyoshi, Hideaki; Atsumi, TatsuyaLog-linear relationship between endogenous insulin secretion and glycemic variability in patients with type 2 diabetes on continuous glucose monitoring-Scientific reports-27-Apr-2021
articleHanda, Takahisa; Nakamura, Akinobu; Miya, Aika; Nomoto, Hiroshi; Kameda, Hiraku; Cho, Kyu Yong; Nagai, So; Yoshioka, Narihito; Miyoshi, Hideaki; Atsumi, TatsuyaThe association between hypoglycemia and glycemic variability in elderly patients with type 2 diabetes: a prospective observational study-Diabetology and metabolic syndrome-1-Apr-2021
articleChiba, Koki; Nomoto, Hiroshi; Nakamura, Akinobu; Cho, Kyu Yong; Yamashita, Kumiko; Shibayama, Yui; Miya, Aika; Kameda, Hiraku; Kurihara, Yoshio; Aoki, Shin; Atsumi, Tatsuya; Miyoshi, HideakiSodium–glucose cotransporter 2 inhibitors reduce day-to-day glucose variability in patients with type 1 diabetes-Journal of Diabetes Investigation-Feb-2021
articleChiba, Koki; Nomoto, Hiroshi; Nakamura, Akinobu; Cho, Kyu Yong; Yamashita, Kumiko; Shibayama, Yui; Miya, Aika; Kameda, Hiraku; Kurihara, Yoshio; Aoki, Shin; Atsumi, Tatsuya; Miyoshi, HideakiSodium-glucose cotransporter 2 inhibitors reduce day-to-day glucose variability in patients with type 1 diabetes-Journal of diabetes investigation-Feb-2021
datasetMiya, Aika; Nakamura, Akinobu; Handa, Takahisa; Nomoto, Hiroshi; Kameda, Hiraku; Cho, Kyu Yong; Nagai, So; Ito, Yoichi M.; Miyoshi, Hideaki; Atsumi, Tatsuya[Dataset] Relationships between clinically relevant factors and log-transformed LBGI, according to multiple regression analysis ---22-Dec-2020
datasetMiya, Aika; Nakamura, Akinobu; Handa, Takahisa; Nomoto, Hiroshi; Kameda, Hiraku; Cho, Kyu Yong; Nagai, So; Ito, Yoichi M.; Miyoshi, Hideaki; Atsumi, Tatsuya[Dataset] Correlations between low blood glucose index and clinical factors ---22-Dec-2020
datasetMiya, Aika; Nakamura, Akinobu; Handa, Takahisa; Nomoto, Hiroshi; Kameda, Hiraku; Cho, Kyu Yong; Nagai, So; Ito, Yoichi M.; Miyoshi, Hideaki; Atsumi, Tatsuya[Dataset] Correlations in the items associated with coefficient of variation ---22-Dec-2020
datasetMiya, Aika; Nakamura, Akinobu; Handa, Takahisa; Nomoto, Hiroshi; Kameda, Hiraku; Cho, Kyu Yong; Nagai, So; Ito, Yoichi M.; Miyoshi, Hideaki; Atsumi, Tatsuya[Dataset] The calculated variance inflation factors ---22-Dec-2020
datasetMiya, Aika; Nakamura, Akinobu; Handa, Takahisa; Nomoto, Hiroshi; Kameda, Hiraku; Cho, Kyu Yong; Nagai, So; Ito, Yoichi M.; Miyoshi, Hideaki; Atsumi, Tatsuya[Dataset] The coefficient of variation distribution among the three C-peptide subgroups ---22-Dec-2020
datasetMiya, Aika; Nakamura, Akinobu; Handa, Takahisa; Nomoto, Hiroshi; Kameda, Hiraku; Cho, Kyu Yong; Nagai, So; Ito, Yoichi M.; Miyoshi, Hideaki; Atsumi, Tatsuya[Dataset] The scatter plot for coefficient of variation ---22-Dec-2020
Showing results 1 to 20 of 32
 next >

 

Hokkaido University